A multivalent HIV-vaccine: development of a plasmid DNA for the expression of HIV envelope glycoproteins with hypervariable V3-loop domains

Vaccine. 2006 May 22;24(21):4648-50. doi: 10.1016/j.vaccine.2005.08.050. Epub 2005 Aug 30.

Abstract

The third hypervariable (V3) loop of the HIV-1 envelope glycoprotein gp120 plays an essential role in the process of viral entry. It contributes to the tropism, coreceptor usage and immune-escape of the virus. We generated a monovalent plasmid DNA and demonstrated the expression of HIV-1 clade B subtype NL4-3 gp120 and gp160 in comparison to a multivalent plasmid DNA encoding for a variety of V3-variants. In contrast to the membrane-anchored gp160, preliminary data demonstrate the monovariant gp120 is expressed in and presented on a human dendritic cell (DC) line, due to a HIVenv-specific re-stimulation of naïve T-cells detected by IFNgamma-ELISPOT assay.

MeSH terms

  • AIDS Vaccines*
  • Amino Acid Sequence
  • HIV Envelope Protein gp120 / chemistry*
  • Molecular Sequence Data
  • Peptide Fragments / chemistry*
  • Sequence Homology, Amino Acid
  • Vaccines, DNA*
  • Viral Envelope Proteins / genetics*

Substances

  • AIDS Vaccines
  • HIV Envelope Protein gp120
  • HIV envelope protein gp120 (305-321)
  • Peptide Fragments
  • Vaccines, DNA
  • Viral Envelope Proteins